financetom
Business
financetom
/
Business
/
Taysha Gene Therapies Commences Offering of Common Stock, Warrants
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taysha Gene Therapies Commences Offering of Common Stock, Warrants
May 28, 2025 2:29 PM

05:10 PM EDT, 05/28/2025 (MT Newswires) -- Taysha Gene Therapies ( TSHA ) unveiled late on Wednesday an offering of common stock and pre-funded warrants to purchase its shares.

The company intends to grant underwriters a 30-day option to purchase up to an additional 15% of the total shares in the offering. It will offer all the shares in the proposed sale.

Shares jumped 16% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zillow Group Insider Sold Shares Worth $650,155, According to a Recent SEC Filing
Zillow Group Insider Sold Shares Worth $650,155, According to a Recent SEC Filing
Nov 14, 2025
05:43 PM EST, 11/14/2025 (MT Newswires) -- Dan Spaulding, Chief People Officer, on November 12, 2025, sold 9,274 shares in Zillow Group ( ZG ) (Z, ZG) for $650,155. Following the Form 4 filing with the SEC, Spaulding has control over a total of 50,342 Class C capital shares of the company, with 50,342 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1617640/000162828025052429/xslF345X05/wk-form4_1763159925.xml...
Sarepta Shares Jump After FDA Approves Updated Elevidys Label
Sarepta Shares Jump After FDA Approves Updated Elevidys Label
Nov 14, 2025
Sarepta Therapeutics, Inc. ( SRPT ) stock jumped on Friday after the FDA issued a new boxed warning for Elevidys. The updated approval follows recent reports of fatal liver injury in non-ambulatory pediatric patients who received the gene therapy.  SRPT stock is moving. Watch the price action here.  The FDA has updated the labeling for Elevidys, a gene therapy for...
SLB Insider Sold Shares Worth $1,412,927, According to a Recent SEC Filing
SLB Insider Sold Shares Worth $1,412,927, According to a Recent SEC Filing
Nov 14, 2025
05:44 PM EST, 11/14/2025 (MT Newswires) -- Stephane Biguet, Executive Vice President & CFO, on November 13, 2025, sold 38,447 shares in SLB (SLB) for $1,412,927. Following the Form 4 filing with the SEC, Biguet has control over a total of 175,690 common shares of the company, with 175,690 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/87347/000008734725000014/xslF345X05/form4.xml ...
Zillow Group Insider Sold Shares Worth $543,490, According to a Recent SEC Filing
Zillow Group Insider Sold Shares Worth $543,490, According to a Recent SEC Filing
Nov 14, 2025
05:51 PM EST, 11/14/2025 (MT Newswires) -- Errol G Samuelson, Chief Industry Development Officer, on November 12, 2025, sold 7,641 shares in Zillow Group ( ZG ) (Z, ZG) for $543,490. Following the Form 4 filing with the SEC, Samuelson has control over a total of 120,815 Class C capital shares of the company, with 120,815 shares held directly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved